Article Details
Retrieved on: 2021-11-29 18:18:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vyjuvek was effective in healing the majority of dystrophic epidermolysis bullosa wounds in a phase 3 trial, Krystal Biotech announced in a press ...
Article found on: www.healio.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here